SCHEMBL24029943

SCHEMBL24029943

COc1ccc(-c2ccc(=O)n(CC(N)=O)n2)cn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 1/20 0.49
MKNK2 Q9HBH9 1/20 0.49
KDM4E B2RXH2 2/20 0.48
ALDH1A1 P00352 2/20 0.48
HSD17B10 Q99714 2/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
LMNA P02545 2/20 0.47
KLK3 P07288 1/20 0.47
TSHR P16473 1/20 0.46
POLB P06746 2/20 0.46
HTT P42858 1/20 0.45
USP2 O75604 1/20 0.44
PKM P14618 1/20 0.44
ALOX15 P16050 1/20 0.44
ATM Q13315 1/20 0.44
MAPT P10636 2/20 0.44
PIK3CA P42336 1/20 0.44
MTOR P42345 1/20 0.44
PDE4A P27815 2/20 0.44
PDE4B Q07343 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24029946 0.84 KDM4E (0.43) KDM4EALDH1A1HSD17B10SMN1; SMN2LMNA
SCHEMBL24030193 0.83 CYP1A2 (0.53) KDM4EALDH1A1HSD17B10SMN1; SMN2LMNA
SCHEMBL29457946 0.83 LMNA (0.64) KDM4EALDH1A1HSD17B10SMN1; SMN2LMNA
SCHEMBL23495359 0.82 KDM4E (0.52) KDM4EALDH1A1HSD17B10LMNAPOLB
SCHEMBL26364786 0.81 POLB (0.43) KDM4EALDH1A1HSD17B10SMN1; SMN2LMNA
SCHEMBL30297703 0.80 KDM4E (0.45) KDM4EALDH1A1HSD17B10SMN1; SMN2LMNA
SCHEMBL25969107 0.79 KDM4E (0.69) KDM4EALDH1A1HSD17B10SMN1; SMN2TSHR
SCHEMBL2969915 0.78 PDE4B (0.67) KDM4EALDH1A1SMN1; SMN2LMNAPOLB
SCHEMBL23297341 0.77 PDE4A (0.53) KDM4EALDH1A1SMN1; SMN2TSHRPOLB
SCHEMBL26627234 0.77 PDE4A (0.53) KDM4ESMN1; SMN2POLBMAPTPDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021231546-A1 SUBSTITUTED PYRIDAZINONE FOR USE IN THE TREATMENT OF NEUROMUSCULAR DISEASES EDGEWISE THERAPEUTICS, INC. (US) 2021-11-18 WO disclosed